BACKGROUND: Rheumatoid arthritis (RA) is currently thought to be an immune-mediated disease where the host's genes and environmental factors interact. Some of the immuno-regulatory genes that are responsible for an individual's susceptibility to RA have been identified. The co-stimulatory receptor gene cluster on chromosome 2q33 encodes for both the positive T-cell regulators CD28 molecule (CD28) and inducible T-cell co-stimulator (ICOS), and the negative regulator cytotoxic T-lymphocyte-associated protein 4 (CTLA4). The CTLA4 gene has been implicated in several immune-mediated diseases, but it is not known whether RA is associated with any of these genes. METHODS: We conducted single nucleotide polymorphism (SNP) genotyping with direct sequencing and restriction fragment length polymorphism for 308 Korean patients with RA and 412 healthy control subjects. For the case-control analysis, SNPStats, SNPAnalyzer and Helixtree programs were used. RESULTS: Although none of the polymorphisms in CTLA4 showed a significant association with RA, CD28 and ICOS showed a significant association with RA [rs2140148 in CD28, p = 0.022, odds ratio (OR) = 1.60, 95% confidence interval (CI) = 1.07-2.40 in the dominant model, rs6726035 in ICOS, p = 0.032, OR = 1.28, 95% CI = 1.02-1.60 in the codominant model]. CONCLUSIONS: Our results suggest that CD28 and ICOS genes may be associated with a risk of RA in Koreans.
BACKGROUND:Rheumatoid arthritis (RA) is currently thought to be an immune-mediated disease where the host's genes and environmental factors interact. Some of the immuno-regulatory genes that are responsible for an individual's susceptibility to RA have been identified. The co-stimulatory receptor gene cluster on chromosome 2q33 encodes for both the positive T-cell regulators CD28 molecule (CD28) and inducible T-cell co-stimulator (ICOS), and the negative regulator cytotoxic T-lymphocyte-associated protein 4 (CTLA4). The CTLA4 gene has been implicated in several immune-mediated diseases, but it is not known whether RA is associated with any of these genes. METHODS: We conducted single nucleotide polymorphism (SNP) genotyping with direct sequencing and restriction fragment length polymorphism for 308 Korean patients with RA and 412 healthy control subjects. For the case-control analysis, SNPStats, SNPAnalyzer and Helixtree programs were used. RESULTS: Although none of the polymorphisms in CTLA4 showed a significant association with RA, CD28 and ICOS showed a significant association with RA [rs2140148 in CD28, p = 0.022, odds ratio (OR) = 1.60, 95% confidence interval (CI) = 1.07-2.40 in the dominant model, rs6726035 in ICOS, p = 0.032, OR = 1.28, 95% CI = 1.02-1.60 in the codominant model]. CONCLUSIONS: Our results suggest that CD28 and ICOS genes may be associated with a risk of RA in Koreans.
Authors: Min Kyung Shin; So Hee Im; Hae Jeong Park; Su Kang Kim; Sung Vin Yim; Joo-Ho Chung; Mu-Hyoung Lee Journal: Exp Ther Med Date: 2011-08-03 Impact factor: 2.447
Authors: K Olasz; F Boldizsar; K Kis-Toth; O Tarjanyi; A Hegyi; W van Eden; T A Rauch; K Mikecz; T T Glant Journal: Clin Exp Immunol Date: 2012-02 Impact factor: 4.330
Authors: Young Rae Ji; Hei Jung Kim; Dong Hoon Yu; Ki Beom Bae; Seo Jin Park; Jun Koo Yi; Nari Kim; Si Jun Park; Keon Bong Oh; Sung Soo Hwang; Sanggyu Lee; Sung-Hyun Kim; Myoung Ok Kim; Jeong Woong Lee; Zae Young Ryoo Journal: J Biol Chem Date: 2012-10-12 Impact factor: 5.157
Authors: G Conteduca; A Rossi; F Megiorni; A Parodi; F Ferrera; S Tardito; F Battaglia; F Kalli; S Negrini; A Pizzuti; E Rizza; F Indiveri; D Fenoglio; G Filaci Journal: Clin Exp Med Date: 2012-11-30 Impact factor: 3.984
Authors: Agata Kosmaczewska; Lidia Ciszak; Jerzy Swierkot; Aleksandra Szteblich; Piotr Wiland; Irena Frydecka Journal: Pathol Oncol Res Date: 2013-09-10 Impact factor: 3.201